Literature DB >> 8561039

Transplantation of cultured sympathetic ganglionic neurons into parkinsonian rat brain: survival and function of graft.

N Nakao1, T Itakura, Y Uematsu, N Komai.   

Abstract

The superior cervical ganglia (SCG) of newborn rats, which had been cultured as explants for varying periods of time, were transplanted into the striatum of rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal dopamine pathway to examine the survival and functional properties of the sympathetic neurons maintained in long-term culture prior to grafting. In the rats given the SCG cultured in vitro for 2 weeks, apomorphine-induced rotational behaviour was satisfactory reduced. The rats receiving the SCG from 4-week-old cultures showed only modest behavioural changes. The grafting of the SCG cultured for 6 weeks in vitro did not affect the rotational behaviour. These behavioural data corresponded with the histological assessment of the graft survival by use of catecholamine histofluorescence. The present results suggest the critical time period in vitro which might allow the cultured sympathetic neurons to be successfully grafted.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8561039     DOI: 10.1007/bf01404950

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  36 in total

1.  Hydrocortisone-induced increase in the number of small intensely fluorescent cells and their histochemically demonstrable catecholamine content in cultures of sympathetic ganglia of the newborn rat.

Authors:  O Eränkö; L Eränkö; C E Hill; G Burnstock
Journal:  Histochem J       Date:  1972-01

Review 2.  Physiology of nerve growth factor.

Authors:  H Thoenen; Y A Barde
Journal:  Physiol Rev       Date:  1980-10       Impact factor: 37.312

3.  Low molecular weight agents support survival of cultured neurons from the central nervous system.

Authors:  S Varon; S D Skaper; G Barbin; I Selak; M Manthorpe
Journal:  J Neurosci       Date:  1984-03       Impact factor: 6.167

4.  Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro.

Authors:  P Brundin; G Barbin; R E Strecker; O Isacson; A Prochiantz; A Björklund
Journal:  Brain Res       Date:  1988-04-01       Impact factor: 3.252

5.  Autologous transplantation of the superior cervical ganglion into the brain of parkinsonian monkeys.

Authors:  M Nakai; T Itakura; I Kamei; K Nakai; Y Naka; H Imai; N Komai
Journal:  J Neurosurg       Date:  1990-01       Impact factor: 5.115

6.  Autotransplantation of the superior cervical ganglion into the brain. A possible therapy for Parkinson's disease.

Authors:  T Itakura; I Kamei; K Nakai; Y Naka; K Nakakita; H Imai; N Komai
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

7.  Catecholamine content of intracerebral adrenal medulla grafts.

Authors:  W J Freed; F Karoum; H E Spoor; J M Morihisa; L Olson; R J Wyatt
Journal:  Brain Res       Date:  1983-06-13       Impact factor: 3.252

8.  Small intensely fluorescent cells in culture: role of glucocorticoids and growth factors in their development and interconversions with other neural crest derivatives.

Authors:  A J Doupe; P H Patterson; S C Landis
Journal:  J Neurosci       Date:  1985-08       Impact factor: 6.167

9.  Functional recovery in a rat model of Parkinson's disease following transplantation of cultured human sympathetic neurons.

Authors:  H Kamo; S U Kim; P L McGeer; D H Shin
Journal:  Brain Res       Date:  1986-11-12       Impact factor: 3.252

10.  Cellular localization of nerve growth factor synthesis by in situ hybridization.

Authors:  C E Bandtlow; R Heumann; M E Schwab; H Thoenen
Journal:  EMBO J       Date:  1987-04       Impact factor: 11.598

View more
  3 in total

Review 1.  Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.

Authors:  Varduhi H Knaryan; Supriti Samantaray; Charlene Le Gal; Swapan K Ray; Naren L Banik
Journal:  J Neurochem       Date:  2011-06-17       Impact factor: 5.372

Review 2.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

Review 3.  Cell based therapies in Parkinson's Disease.

Authors:  Madhuri Behari; Kapil Kumar Singhal
Journal:  Ann Neurosci       Date:  2011-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.